Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of an antiallergic agent in Japan
jRCT2080224623Phase 3Completed
- Start
- Apr 2019
01
Overview
Phase 3 trial in allergy. Started Apr 2019; status: completed.
02
Conditions
allergy
Beyond the preview
Go deeper on jRCT2080224623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224623.